These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12384495)

  • 1. Identification of a potent and orally active non-peptide C5a receptor antagonist.
    Sumichika H; Sakata K; Sato N; Takeshita S; Ishibuchi S; Nakamura M; Kamahori T; Ehara S; Itoh K; Ohtsuka T; Ohbora T; Mishina T; Komatsu H; Naka Y
    J Biol Chem; 2002 Dec; 277(51):49403-7. PubMed ID: 12384495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel C5a receptor antagonists regulate neutrophil functions in vitro and in vivo.
    Pellas TC; Boyar W; van Oostrum J; Wasvary J; Fryer LR; Pastor G; Sills M; Braunwalder A; Yarwood DR; Kramer R; Kimble E; Hadala J; Haston W; Moreira-Ludewig R; Uziel-Fusi S; Peters P; Bill K; Wennogle LP
    J Immunol; 1998 Jun; 160(11):5616-21. PubMed ID: 9605167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of C5a-induced neutrophil chemotaxis and macrophage cytokine production in vitro by a new C5a receptor antagonist.
    Haynes DR; Harkin DG; Bignold LP; Hutchens MJ; Taylor SM; Fairlie DP
    Biochem Pharmacol; 2000 Sep; 60(5):729-33. PubMed ID: 10927032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection of innate immunity by C5aR antagonist in septic mice.
    Huber-Lang MS; Riedeman NC; Sarma JV; Younkin EM; McGuire SR; Laudes IJ; Lu KT; Guo RF; Neff TA; Padgaonkar VA; Lambris JD; Spruce L; Mastellos D; Zetoune FS; Ward PA
    FASEB J; 2002 Oct; 16(12):1567-74. PubMed ID: 12374779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of a C5a receptor antagonist from phage libraries attenuating the inflammatory response in immune complex disease and ischemia/reperfusion injury.
    Heller T; Hennecke M; Baumann U; Gessner JE; zu Vilsendorf AM; Baensch M; Boulay F; Kola A; Klos A; Bautsch W; Köhl J
    J Immunol; 1999 Jul; 163(2):985-94. PubMed ID: 10395696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of a new C5a receptor antagonist on C5a- and endotoxin-induced neutropenia in the rat.
    Short A; Wong AK; Finch AM; Haaima G; Shiels IA; Fairlie DP; Taylor SM
    Br J Pharmacol; 1999 Feb; 126(3):551-4. PubMed ID: 10188960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species dependence for binding of small molecule agonist and antagonists to the C5a receptor on polymorphonuclear leukocytes.
    Woodruff TM; Strachan AJ; Sanderson SD; Monk PN; Wong AK; Fairlie DP; Taylor SM
    Inflammation; 2001 Jun; 25(3):171-7. PubMed ID: 11403208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activities of decapeptide agonists of human C5a: the conformational effects of backbone N-methylation.
    Vogen SM; Paczkowski NJ; Kirnarsky L; Short A; Whitmore JB; Sherman SA; Taylor SM; Sanderson SD
    Int Immunopharmacol; 2001 Nov; 1(12):2151-62. PubMed ID: 11710544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Concentration of C5a-Induced Mitochondria-Dependent Apoptosis in Murine Kidney Endothelial Cells.
    Tsai IJ; Lin WC; Yang YH; Tseng YL; Lin YH; Chou CH; Tsau YK
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31510052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury.
    Proctor LM; Arumugam TV; Shiels I; Reid RC; Fairlie DP; Taylor SM
    Br J Pharmacol; 2004 Jun; 142(4):756-64. PubMed ID: 15159277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of immune-complex mediated dermal inflammation in rats following either oral or topical administration of a small molecule C5a receptor antagonist.
    Strachan AJ; Shiels IA; Reid RC; Fairlie DP; Taylor SM
    Br J Pharmacol; 2001 Dec; 134(8):1778-86. PubMed ID: 11739255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonistic peptides against human anaphylatoxin C5a.
    Kaneko Y; Okada N; Baranyi L; Azuma T; Okada H
    Immunology; 1995 Sep; 86(1):149-54. PubMed ID: 7590876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 down-regulates anaphylatoxin receptors in monocytes and dendritic cells and impairs anaphylatoxin-induced migration in vivo.
    Soruri A; Kiafard Z; Dettmer C; Riggert J; Köhl J; Zwirner J
    J Immunol; 2003 Mar; 170(6):3306-14. PubMed ID: 12626590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of NDT 9513727 [N,N-bis(1,3-benzodioxol-5-ylmethyl)-1-butyl-2,4-diphenyl-1H-imidazole-5-methanamine], a novel, orally bioavailable C5a receptor inverse agonist.
    Brodbeck RM; Cortright DN; Kieltyka AP; Yu J; Baltazar CO; Buck ME; Meade R; Maynard GD; Thurkauf A; Chien DS; Hutchison AJ; Krause JE
    J Pharmacol Exp Ther; 2008 Dec; 327(3):898-909. PubMed ID: 18753409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small molecular probes for G-protein-coupled C5a receptors: conformationally constrained antagonists derived from the C terminus of the human plasma protein C5a.
    Wong AK; Finch AM; Pierens GK; Craik DJ; Taylor SM; Fairlie DP
    J Med Chem; 1998 Aug; 41(18):3417-25. PubMed ID: 9719594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A functional C5a anaphylatoxin receptor in a teleost species.
    Holland MC; Lambris JD
    J Immunol; 2004 Jan; 172(1):349-55. PubMed ID: 14688343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of C5a receptors on human eosinophils and inhibition of eosinophil effector functions by anti-C5a receptor (CD88) antibodies.
    Elsner J; Oppermann M; Kapp A
    Eur J Immunol; 1996 Jul; 26(7):1560-4. PubMed ID: 8766561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent cyclic antagonists of the complement C5a receptor on human polymorphonuclear leukocytes. Relationships between structures and activity.
    March DR; Proctor LM; Stoermer MJ; Sbaglia R; Abbenante G; Reid RC; Woodruff TM; Wadi K; Paczkowski N; Tyndall JD; Taylor SM; Fairlie DP
    Mol Pharmacol; 2004 Apr; 65(4):868-79. PubMed ID: 15044616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models.
    Ames RS; Lee D; Foley JJ; Jurewicz AJ; Tornetta MA; Bautsch W; Settmacher B; Klos A; Erhard KF; Cousins RD; Sulpizio AC; Hieble JP; McCafferty G; Ward KW; Adams JL; Bondinell WE; Underwood DC; Osborn RR; Badger AM; Sarau HM
    J Immunol; 2001 May; 166(10):6341-8. PubMed ID: 11342658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-function relationships of human C5a and C5aR.
    Huber-Lang MS; Sarma JV; McGuire SR; Lu KT; Padgaonkar VA; Younkin EM; Guo RF; Weber CH; Zuiderweg ER; Zetoune FS; Ward PA
    J Immunol; 2003 Jun; 170(12):6115-24. PubMed ID: 12794141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.